Oxford Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,357
| Closed | -$154K | – | 584 |
|
|
2025
Q1 | $154K | Buy |
+28,357
| New | +$154K | 0.07% | 379 |
|
|
2018
Q3 | – | Sell |
-5,977
| Closed | -$121K | – | 1751 |
|
|
2018
Q2 | $121K | Buy |
5,977
+4,444
| +290% | +$90K | ﹤0.01% | 1630 |
|
|
2018
Q1 | $19K | Sell |
1,533
-6,751
| -81% | -$83.7K | ﹤0.01% | 1563 |
|
|
2017
Q4 | $87K | Buy |
8,284
+3,138
| +61% | +$33K | ﹤0.01% | 1531 |
|
|
2017
Q3 | $62K | Sell |
5,146
-1,754
| -25% | -$21.1K | ﹤0.01% | 1490 |
|
|
2017
Q2 | $118K | Buy |
+6,900
| New | +$118K | ﹤0.01% | 1406 |
|
|
2016
Q1 | – | Sell |
-3,065
| Closed | -$147K | – | 831 |
|
|
2015
Q4 | $147K | Buy |
+3,065
| New | +$147K | ﹤0.01% | 819 |
|